Aurobindo Pharma announced that its subsidiary, CuraTeQ Biologics has expanded the scope of its marketing and distribution agreement with Orion Corporation to commercialize its biosimilars pipeline to include the Baltic states in Europe.
At meeting held on 11 January 2022
At meeting held on 11 January 2022
Marksans Pharma has received final approval from US Food & Drugs Administration for its Abbreviated New Drug Application (ANDA) for over the counter (OTC) Cetirizine Hydrochloride Tablets 5 mg and 10mg. It is indicated for the treatment of the perennial allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes, running nose. The product will be marketed under store brand labels and is comparable to the […]
The company has appointed HDFC Bank Limited as ‘Issuing & Paying Agent’ for this issuance.
Airan Limited has entered into a Service Agreement with Standard Chartered Bank, for the outsourcing of their various transaction processing activities through CTS (Cheque Truncation System), CMS (Cash Management Services)
Pursuant to conversion of warrants into equity shares
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
